---
title: "China Health Group Announces Board Composition and Committee Roles"
description: "China Health Group (HK:0673) has announced its board composition and committee roles, detailing the executive, non-executive, and independent non-executive directors, along with the members and chairp"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/263760542.md"
published_at: "2025-10-31T13:19:33.000Z"
---

# China Health Group Announces Board Composition and Committee Roles

> China Health Group (HK:0673) has announced its board composition and committee roles, detailing the executive, non-executive, and independent non-executive directors, along with the members and chairpersons of its audit, nomination, and remuneration committees. This update clarifies the company's governance structure, which may influence its strategic direction. The current analyst rating for the stock is a Hold with a price target of HK$0.50, and the market cap stands at HK$669.6M.

China Health Group ( (HK:0673) ) just unveiled an announcement.

China Health Group Limited, a company incorporated in Bermuda and operating in Hong Kong as CHG HS Limited, has announced the composition of its board of directors and the roles within its three board committees. The announcement details the executive, non-executive, and independent non-executive directors, as well as the members and chairpersons of the audit, nomination, and remuneration committees. This update provides stakeholders with clarity on the governance structure of the company, potentially impacting its strategic direction and operational oversight.

The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.

**More about China Health Group**

**Average Trading Volume:** 665,568

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$669.6M

### Related Stocks

- [00673.HK - CHINA HEALTH](https://longbridge.com/en/quote/00673.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| China Health Group kündigt Ausgabe von 48 Millionen neuen Aktien an | China Health Group Ltd. has announced the issuance of 48,000,000 new shares under a subscription agreement. The new shar | [Link](https://longbridge.com/en/news/274530078.md) |
| China Health Group Inc. Announces New AI-Driven Clinical Research Focus and Exclusive Rights for Innovative Dementia Treatment | China Health Group Inc. has announced a new focus on AI-driven clinical research, hosting the "AI-RWS Real-World Study S | [Link](https://longbridge.com/en/news/257288269.md) |
| Will China Literature Turn The Page? | China Literature Ltd. expects a net loss of up to 850 million yuan for last year, primarily due to a 1.8 billion yuan go | [Link](https://longbridge.com/en/news/276113491.md) |
| ZAWYA-PRESSR: Al Ghurair signs exclusive agreement to distribute Dongfeng’s MHero brand in United Arab Emirates | Al Ghurair Mobility has signed an exclusive agreement with Dongfeng Motor Corporation to distribute the MHero brand in t | [Link](https://longbridge.com/en/news/276207796.md) |
| China Health Group Inc. Says No Known Reason for Recent Share Price Movement | China Health Group Inc. has stated that it is unaware of any reasons for the recent increase in its share price and trad | [Link](https://longbridge.com/en/news/263751011.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.